York, Pa, August 27, 2024 – The AFDO/RAPS Healthcare Products Collaborative announced today that registration is now open for the AI Global Healthcare Initiative’s AI Summit 2024, taking place November 13-14 at the Westin Cincinnati in Ohio. This annual summit brings together regulatory authorities, healthcare leaders, and AI experts across industry, government, and academia to collaborate for our patients and elevate the industry as a whole. Through interactive sessions, hands-on workshops, and purpose-driven discussions, attendees will tackle hurdles to AI adoption and implement solutions that advance patient care.
A Strategic Committee of industry experts guides the AI Summit program development. The Strategic Committee includes:
- Pat Baird, Regulatory Head of Global Software Standards, Philips
- Matthew Diamond, Chief Medical Officer, Digital Health Center of Excellence, FDA
- Brian Edwards, Fellow, Regulatory Affairs, Digital Health/Cybersecurity, Boston Scientific
- Steve Frigon, Data Integration Team Lead, The Chris Hospital Health Network
- Lacey Harbour, Regulatory Affairs Manager, Thermo Fisher Scientific
- Eric Henry, Senior Quality & Regulatory Compliance Advisor, FDA & Life Sciences Practice, King & Spalding
- Cindy Ipach, President & CEO, Compliance Insight
- Rohit Nayak, CEO, Electronic Registry Systems, Inc.
- Alison Sathe, Senior Vice President, Data Strategy & Analytics, Redica Systems
- Cassie Scherer, Senior Director U.S. Regulatory and Global Digital Health Policy, Medtronic
- Matthew Schmucki, Associate Director of Automation Engineering, Vertex Pharmaceuticals
- Bradley Thompson, Attorney and Chief Data Scientist focused on FDA, FTC & AI Regulation, Epstein Becker & Green
- Mohammed Wahab, Quality Head, Professional Services – Informatics & Analytics, Abbott Laboratories
The AI Summit agenda features interactive sessions that create a behind-the-scenes experience in how AI is being used in pharma, biopharma, and medical devices. Topics covered will include emerging AI applications, understanding and managing bias in AI, cybersecurity, and the AI software development lifecycle. In addition, attendees will hear about updates on the global AI/ML regulations and standards, the FDA’s PCCP draft guidance and insights from the FDA Digital Health Center of Excellence. To learn more and register, visit the AI Summit website.
